Announcement • Jul 28

NuGen Medical Devices Inc. Files Additional Patent Applications for Needle-Free Drug Delivery Platforms

NuGen Medical Devices Inc. announced the filing of two additional patent applications supporting its current patent portfolio. The new applications focus on high-efficiency spring charging technology and automatic dose-establishment technology. Together with previously announced patent applications relating to the Company's dual-spring injection system, refill platform and prefilled nozzle platform, NuGen believes it has now established the core intellectual property portfolio supporting its needle-free drug delivery technologies. The technologies were designed at NuGen's innovation hub in the Netherlands and represent an evolution beyond the Company's current InsuJet platform. While InsuJet has been continuously refined and improved over many years, its underlying architecture remains based on an earlier generation of needle-free delivery technology that cannot fully match the simplicity and ease of use patients have come to expect from modern insulin delivery systems such as insulin pens. The newly announced innovations are designed from the ground up to simplify operation, improve convenience and reduce user training requirements. The Company's objective is straightforward: any patient who can use an insulin pen should be able to use NuGen's needle-free technology. The Company's future platform family consists of three complementary platform categories: 1. Transfer Platform – a flexible needle-free delivery system designed to deliver medication directly from existing drug containers; 2. Refill Platform – a reusable injector technology paired with replaceable refill cartridges for chronic therapies; and 3. Prefilled Platform – an integrated pharmaceutical packaging and fixed-dose, needle-free delivery solution. The newly filed patent applications focus on simplifying the user experience by reducing spring-setting effort and enabling automatic device configuration based on the installed prefilled container. Together with NuGen’s previously announced patent portfolio, these innovations establish a strong technical foundation for future products that are easier to use, deliver more consistent performance, and support a broad range of pharmaceutical applications.

NuGen Medical Devices Inc. Stock Price

NGMD Share Price Performance

NGMD Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

NuGen Medical Devices Inc. Key Details

About NGMD

Recent NGMD News & Updates

NuGen Medical Devices Inc. (TSXV:NGMD) signed a letter of intent to acquire Sol-Millennium Medical, Inc. from Sol-Millennium Medical Group.

NuGen Medical Devices Inc. Files Additional Patent Applications for Needle-Free Drug Delivery Platforms

NuGen Medical Devices Inc., Annual General Meeting, Sep 21, 2026

Recent updates

NuGen Medical Devices Inc. Competitors

Apptly Health Technologies

Unidoc Health

Pangenomic Health

Leveljump Healthcare